Skip to content

KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease

KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease : A 10-year Longitudinal Cohort Study of the Chronic Kidney Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02165878
Acronym
KNOW-PedCKD
Enrollment
458
Registered
2014-06-18
Start date
2011-03-31
Completion date
2021-12-31
Last updated
2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease(CKD)

Keywords

Chronic kidney disease(CKD)

Brief summary

KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease) is a nation-wide, ten-year longitudinal cohort study, launched in 2011. The aim of the study is to assess the characteristics and risk factors of progression and complications of CKD of Korea. Pediatric sub-cohort of KNOW-CKD is planned to enroll 450 children with CKD, stage I to V (pre-dialysis).

Detailed description

Seven major pediatric nephrology centers of Korea enrolled children younger than 20 years who had CKD. Medical history taking, questionaire assessment of socio-economic status, anthropometric measurement, and clinical assessment using laboratory and imaging tests were done. Outcome is development of LV hypertrophy or hypertension, growth, neuropsychological status, behavioral status, kidney growth, and quality of life.

Interventions

None listed

Sponsors

Jeju National University Hospital
CollaboratorOTHER
Pusan National University Hospital
CollaboratorOTHER
Samsung Medical Center
CollaboratorOTHER
Kyungpook National University Hospital
CollaboratorOTHER
Yonsei University
CollaboratorOTHER
Asan Medical Center
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 20 Years
Healthy volunteers
No

Inclusion criteria

* Age: \< 20 yr * CKD stage 1 through 5 of KDIGO guideline * predialysis

Exclusion criteria

\- Dialysis

Design outcomes

Primary

MeasureTime frameDescription
eGFR10 yearseGFR in mL/min/1.73 m2

Secondary

MeasureTime frameDescription
Development of cardiovascular disease10 yearsHypertrophy in g/m2
Metabolic bone disease10 yearsBone Dexametry in z score
Growth10 yearsHeight in z score
Health-related quality of life (HRQOL)10 yearsPedsQL 4.0 Generic Core Scale Module (Mapi Research Trust, on behalf of Dr James W. Varni, copyright owner of PedsQL™)
Cognitive skills and emotional development10 yearsK-WAIS score
Anemia10 yearsAnemia in g/dL

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026